CONCORD BIOTECH
CONCORD BIOTECH; USFDA Completes Concord Biotech’s Dholka Plant Inspection with 4 Observations USFDA inspection from April 28 to May 2, 2025. Issued Form 483 with 4 procedural observations, no data integrity issues. Concord to submit response and expects quick resolution
#StockInNews#WatchOutFor#FundamentalViews#EquityResearch#PersonalFinance
101 likes·57 comments

















